Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

VERTEX PHARMACEUTICALS INC / MA

Pharmaceutical Preparations | SIC: 2834
Phone: 6173416393

CIK: 0000875320
EIN: 043039129
State Location: MA
State of Inc.: MA

Nasdaq:VRTX

Form: SCHEDULE 13G/A

Filing Date: 14 May 2026
Report Date:
Accepted: 14 May 2026 08:19 a.m.
Accession Number: 0001422848-26-000067

Act: 34
File Number: 005-42126
Film Number: 26976405

Documents

Primary Document

Accepted: 14 May 2026 08:19 a.m.

0001422848-26-000067-index-headers.html

Last Modified: 14 May 2026 08:19 a.m.

0001422848-26-000067-index.html

Last Modified: 14 May 2026 08:19 a.m.

0001422848-26-000067.txt

Last Modified: 14 May 2026 08:19 a.m.

primary_doc.xml

Last Modified: 14 May 2026 08:19 a.m.